Jonathan Mcneill
President and COO · 2 filings · Latest: Sep 16, 2026
CRESCENT BIOPHARMA, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CBIO | Jonathan Mcneill | President and COO | Sep 18, 2026 | Sale | $16.71 | 3,839 | $64.1K | 134,588 | |
CBIO | Jonathan Mcneill | President and COO | Sep 16, 2026 | Sale | $17.90 | 731 | $13.1K | 138,427 | |
CBIO | Jonathan McNeill | — | Sep 18, 2026 | Proposed Sale | $17.18 | 4,415 | $75.8K | — | |
CBIO | Jonathan McNeill | — | Sep 16, 2026 | Proposed Sale | $18.80 | 804 | $15.1K | — | |
CBIO | Jonathan Mcneill | President and COO | Jun 22, 2026 | Sale | $17.99 | 20,549 | $369.7K | 139,158 | |
DYN | McNeill Jonathan | — | Nov 25, 2024 | Proposed Sale | $29.69 | 19,987 | $593.4K | — | |
DYN | McNeill Jonathan | — | Nov 18, 2024 | Proposed Sale | $28.39 | 2,658 | $75.5K | — | |
DYN | McNeill Jonathan | — | Sep 18, 2024 | Proposed Sale | $34.51 | 1,870 | $64.5K | — | |
DYN | McNeill Jonathan | — | Sep 11, 2024 | Proposed Sale | $32.43 | 1,823 | $59.1K | — | |
DYN | McNeill Jonathan | — | Sep 5, 2024 | Proposed Sale | $33.61 | 166,767 | $5.6M | — |